NASDAQ:VERA - Nasdaq - US92337R1014 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 145.28M | 102.01M | 90.90M | 34.40M | 48.06M | |||
Research and Development | 113.61M | 78.22M | 68.99M | 22.48M | 44.17M | |||
Selling, General, and Administrative Expenses | 31.67M | 23.79M | 21.91M | 11.92M | 3.89M | |||
Operating Income | -145.28M | -102.01M | -90.90M | -34.40M | -48.06M | |||
Interest Income/Expense | 9.20M | 4.19M | 760.00K | -10.00K | -160.00K | |||
Other Income/Expense | 1.71M | 1.83M | 1.09M | -890.00K | -1.08M | |||
Non Recurring Items | N/A | N/A | 0.00 | 2.69M | -4.12M | |||
Income Before Taxes | -134.38M | -95.99M | -89.06M | -32.61M | -53.41M | |||
Income Tax | N/A | 1.00K | 0.00 | 0.00 | 0.00 | |||
Net Income | -134.38M | -95.99M | -89.06M | -32.61M | -53.41M | |||
EBITDA | N/A | N/A | N/A | -34.22M | -47.81M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.60 | -2.25 | -3.35 | -1.53 | -2.61 | |||
Non GAAP EPS | -2.63 | -2.31 | -3.35 | -13.71 | N/A | |||
Statistics |
All data in USD